Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5438
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data ; volume:28 ; number:12 ; day:9 ; month:7 ; year:2020 ; pages:1662-1668 ; date:12.2020
European journal of human genetics ; 28, Heft 12 (9.7.2020), 1662-1668, 12.2020
- Urheber
-
Riccio, Eleonora
Zanfardino, Mario
Ferreri, Lucia
Santoro, Ciro
Cocozza, Sirio
Capuano, Ivana
Imbriaco, Massimo
Feriozzi, Sandro
Pisani, Antonio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41431-020-0677-x
- URN
-
urn:nbn:de:101:1-2021011019011849034866
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Riccio, Eleonora
- Zanfardino, Mario
- Ferreri, Lucia
- Santoro, Ciro
- Cocozza, Sirio
- Capuano, Ivana
- Imbriaco, Massimo
- Feriozzi, Sandro
- Pisani, Antonio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year
Histone chaperone exploits intrinsic disorder to switch acetylation specificity
A switch point in the molecular chaperone Hsp90 responding to client interaction
A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
Correction: A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
Molekulare Chaperone
Co-chaperone interactions in the Hsp90 chaperone cycle
Fabry Nephropathy in a Young Female Patient Presenting with Only Urinary Mulberry Bodies Treated with Chaperone Therapy
Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data”
How to switch a master switch
Fabry, Josef
Fabry, Willy
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year
Histone chaperone exploits intrinsic disorder to switch acetylation specificity
A switch point in the molecular chaperone Hsp90 responding to client interaction
A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
Correction: A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
Molekulare Chaperone
Co-chaperone interactions in the Hsp90 chaperone cycle
Fabry Nephropathy in a Young Female Patient Presenting with Only Urinary Mulberry Bodies Treated with Chaperone Therapy
Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data”
How to switch a master switch
Fabry, Josef
Fabry, Willy
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year
Histone chaperone exploits intrinsic disorder to switch acetylation specificity
A switch point in the molecular chaperone Hsp90 responding to client interaction
A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
Correction: A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
Molekulare Chaperone
Co-chaperone interactions in the Hsp90 chaperone cycle
Fabry Nephropathy in a Young Female Patient Presenting with Only Urinary Mulberry Bodies Treated with Chaperone Therapy
Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data”
How to switch a master switch
Fabry, Josef